Back to 
ROYAL BANK OF CANADA
ROYAL BANK OF CANADA
NGEN2 quarters
Position history for ROYAL BANK OF CANADA's holdings in NERVGEN PHARMA CORP
Yes. Royal Bank of Canada holds 176,075 shares of NGEN (Nervgen Pharma), worth $363,000, as of its Q2 2026 13F filing. It increased the position by 4,114 shares (+2.4%) from Q1 2026. Royal Bank of Canada has held NGEN in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$363,000
Current Shares
176,075
Total Value Change
-$285,000
Total Shares Change
+4,114
Quarter-by-Quarter History
Other major holders of NGEN: LMR Partners LLP, MARSHALL WACE, LLP, UBS Group AG, BANK OF AMERICA CORP /DE/